Loyola Pharmaceuticals Nyeri - Chemist/Pharmacy

20/11/2025

https://www.facebook.com/share/v/17PfT7C2Gg/

19/11/2025

A nurse placed the healthy baby next to her dying twin sister... and what happened next truly revolutionized medicine. In 1995, at a Massachusetts hospital, two premature twins, Kyrie and Brielle, were fighting for their lives. Kyrie was gradually getting stronger... but her sister Brielle was growing weaker by the hour. The doctors had already prepared the family for the worst: her heart was beating erratically, her breathing was failing, and no one thought she would make it through the night. Then a nurse, following her instinct rather than the protocol of the time, decided to try something no one else dared: she placed the two babies in the same incubator, skin to skin. What happened next left the entire neonatal unit speechless. The monitors began to change... Brielle's breathing stabilized... her oxygen saturation rose... and against all odds, her little body came back to life. The nurses saw Kyrie slip his tiny arm around his sister, as if to hold her.

A small gesture.
A suspended moment.
A phenomenon that medical records couldn't yet explain.

This simple contact between two lives linked even before birth not only saved a child... but also changed the way hospitals around the world now care for premature twins.

Sometimes, the miracle isn't supernatural.
It lies in an embrace. In the warmth of a loved one.

19/11/2025

You can now WhatsApp your prescription to 0769915500. We respond, quote, & deliver on time.

19/11/2025

Happy International Men's Day to all our male clients. We do appreciate you.

18/11/2025

How Is Scabies Transmitted?

People typically acquire mites after 15 to 20 minutes of direct skin-to-skin contact with another person who has scabies or, rarely, from infested linen and clothing. Risk factors for scabies include living in crowded conditions (sharing close living spaces, staying in a shelter), bed sharing, sexual contact, and caregiving involving close contact.

For enquires, Call/Sms/WhatsApp us on 0769915500.

17/11/2025

Scientists traced HIV/AIDS to Kinshasa (then Léopoldville), with origins between 1909–1930, and the earliest human infections likely appearing in the 1920s.

The genetic history of HIV-1 group M, the strain responsible for the global pandemic, shows that it began circulating in central Africa during this period. Researchers identified chimpanzees as the source, carrying simian immunodeficiency virus (SIV), which crossed into humans through direct contact such as hunting or butchering. According to University of Oxford, HIV jumped from primates to humans at least 13 separate times, but only one of those transmission events HIV-1 group M-led to the global pandemic we know today. The first verified human case of HIV was discovered in a blood sample taken in Kinshasa in 1959, decades before AIDS was recognized in the 1980s.

Once HIV entered humans, it spread quietly for decades. Studies suggest low-level transmission occurred in the Congo basin between 1920 and 1970, with the virus gradually adapting and diversifying. This long incubation period explains why AIDS was not recognized until clusters of immune deficiency cases appeared in the United States in 1981.

By reconstructing HIV’s genetic lineage, scientists confirmed Kinshasa as the epicenter of the pandemic. From there, the virus expanded across Africa and eventually to the Caribbean and beyond, setting the stage for the global epidemic that would later claim millions of lives. Genetic studies show that the virus spread rapidly in the 1960s thanks to Congo’s expanding railways and river routes, which allowed infected individuals to travel widely and unknowingly carry HIV to new regions.

By the time HIV was identified in the 1980s, the virus had already diversified into multiple subtypes. This hidden genetic variety explains why different strains dominate in different parts of the world today.

16/11/2025

Want to consult our pharmacist? Call/Sms/Whatsapp 0769915500.

01/11/2025

29/10/2025

Metabolic arthritis, also known as gout, is a condition characterized by the deposition of monosodium urate crystals in joints and soft tissues. This occurs due to an excess of uric acid in the blood, a condition known as hyperuricemia.

Several factors can contribute to the development of gout, including male gender, middle age (most common), a high-purine diet, alcohol consumption (especially beer), obesity, and renal impairment (which affects urate excretion). Certain medications, such as thiazides, loop diuretics, cyclosporine, pyrazinamide, ethambutol, and low-dose aspirin, can also increase the risk of gout. Additionally, genetic enzyme defects, particularly HGPRT deficiency (Lesch-Nyhan syndrome), can predispose individuals to gout.

The pathophysiology of gout involves an elevated serum uric acid level exceeding 6.8 mg/dL, which leads to the formation of urate crystals in the joints. These crystals activate neutrophils, resulting in the release of inflammatory cytokines such as IL-1, IL-6, and TNF-α, which cause acute inflammation. Recurrent attacks of gout can lead to the development of tophaceous gout and chronic arthritis.

The clinical features of gout typically include sudden and severe joint pain, often occurring at night. The first metatarsophalangeal (MTP) joint is the most commonly affected area, and the affected joint may appear red, hot, swollen, and tender, causing a sensation of “bedsheet intolerance.” In chronic gout, tophi, which are hard deposits of urate crystals, may develop on the ear helix, elbows, and Achilles tendon.

For management and treatment options, Call/Sms/WhatsApp us on 0769915500.

20/10/2025

You are our hero as you have made us who we are. Happy Mashujaa Day! We remain open.